Cardiac Function Improvement and Bone Marrow Response –: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133(+) Application After Myocardial Infarction

OBJECTIVE: The phase III clinical trial PERFECT was designed to assess clinical safety and efficacy of intramyocardial CD133(+) bone marrow stem cell treatment combined with CABG for induction of cardiac repair. DESIGN: Multicentre, double-blinded, randomised placebo controlled trial. SETTING: The s...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinhoff, Gustav, Nesteruk, Julia, Wolfien, Markus, Kundt, Günther, Börgermann, Jochen, David, Robert, Garbade, Jens, Große, Jana, Haverich, Axel, Hennig, Holger, Kaminski, Alexander, Lotz, Joachim, Mohr, Friedrich-Wilhelm, Müller, Paula, Oostendorp, Robert, Ruch, Ulrike, Sarikouch, Samir, Skorska, Anna, Stamm, Christof, Tiedemann, Gudrun, Wagner, Florian Mathias, Wolkenhauer, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552265/
https://www.ncbi.nlm.nih.gov/pubmed/28781130
http://dx.doi.org/10.1016/j.ebiom.2017.07.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552265/
https://www.ncbi.nlm.nih.gov/pubmed/28781130
http://dx.doi.org/10.1016/j.ebiom.2017.07.022

Ejemplares similares